For: | Sun KR, Lv HF, Chen BB, Nie CY, Zhao J, Chen XB. Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1. World J Gastrointest Oncol 2021; 13(4): 216-222 [PMID: 33889273 DOI: 10.4251/wjgo.v13.i4.216] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i4/216.htm |
Number | Citing Articles |
1 |
TIANZHU LI, YU ZHANG, TONG ZHANG, YANNAN LI, HUI XUE, JINGLONG CAO, WENSHUANG HOU, YINGHUA LUO, CHENGHAO JIN. Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways. BIOCELL 2023; 47(1): 195 doi: 10.32604/biocell.2023.025593
|
2 |
Chen Liu, Lin Liu. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1037716
|
3 |
Jiefeng Li, Yating Wang, Ying Deng, Xu Wang, Wenda Wu, Eugenie Nepovimova, Qinghua Wu, Kamil Kuca. Toxic mechanisms of the trichothecenes T-2 toxin and deoxynivalenol on protein synthesis. Food and Chemical Toxicology 2022; 164: 113044 doi: 10.1016/j.fct.2022.113044
|
4 |
Andrés Ramos‐Valle, Arnau Domínguez, Natalia Navarro, Ana Márquez‐López, Anna Aviñó, Ramon Eritja, Carme Fàbrega, Lorena García‐Hevia, Mónica. L. Fanarraga. Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment. Small 2025; 21(20) doi: 10.1002/smll.202407752
|
5 |
Ana Márquez-López, Mónica L. Fanarraga. AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy. International Journal of Molecular Sciences 2023; 24(13): 11227 doi: 10.3390/ijms241311227
|
6 |
Virginia Corbett, Paul Hallenbeck, Piotr Rychahou, Aman Chauhan. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.930207
|
7 |
Samuel A. Kareff, Virginia Corbett, Paul Hallenbeck, Aman Chauhan. TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale. Cells 2023; 12(22): 2623 doi: 10.3390/cells12222623
|